Displaying 69 out of 198 Cambridge companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Qureight HIRING

Qureight is an imaging analytics company.

46
$8M · Series A Guinness Ventures, Hargreave Hale Aim VCT, Ascension Ventures 1 to 10 Health Tech, Machine Learning, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@qureight.com
PragmatIC Semiconductor

Silicon-free chip maker.

46
$228M · Series D Latitude, UK Infrastructure Bank, MVolution Partners 101 to 250 Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@pragmaticsemi.com
ViaNautis

Drug delivery platform.

42
$24M · Series A 4BIO Capital, UCB Ventures, Business Growth Fund 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@vianautis.com
Theia InsightsJUST ADDED

AI-powered investment analytics platform.

42
$6M · Series A Fidelity International Strategic Ventures, Unusual Ventures, Clocktower Technology Ventures 1 to 10 AI, Investing B2B, SaaS Cambridge, UK •••••••••••@theiainsights.com
CMR Surgical

Surgical robotic system for minimal access surgery.

42
$164M · Series D SoftBank Group, Tencent, ABB Technology Ventures 501 to 1000 Health Tech, Robotics B2B Cambridge, UK •••••••••••@cmrsurgical.com
Microbiotica

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

37
$66M Seventure Partners, Cambridge Innovation Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@microbiotica.com
Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

37
$56M · Series B Balderton Capital, Atomico, Amadeus Capital 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Uncommon

Cultured meat manufacturer.

37
$30M · Series A Balderton Capital, Lowercarbon Capital 11 to 50 Climate Tech & Green Tech, Foodtech Cambridge, UK •••••••••••@uncommonbio.co
Zetta Genomics

Genomic data analysis platform.

37
$2M · Seed We Venture Capital, Nina Capital, LinkedIn 11 to 50 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@zettagenomics.com
Sano Genetics

AI platform to advance precision medicine clinical trials.

37
$11M · Series A Seedcamp, Plural, Episode 1 11 to 50 Health Tech, Biotech B2B, SaaS Cambridge, UK •••••••••••@sanogenetics.com
Secondmind

Machine learning for automotive innovators

37
$16M · Series A Amadeus Capital, Mazda Motor Corporation, Cambridge Innovation Capital 51 to 100 AI Cambridge, UK •••••••••••@secondmind.ai
ieso

Transforming mental healthcare by unlocking the power of clinical data

37
$52M · Series B Molten Ventures 101 to 250 Health Tech, Deep Tech B2B, B2C Cambridge, UK •••••••••••@iesogroup.com
Harness Therapeutics

Physiological upregulation therapy to treat neurodegenerative diseases.

37
$5M · Seed SV Health Investors 11 to 50 Health Tech, Biotech Cambridge, UK •••••••••••@harnesstx.com
NeoPhore

Small molecule neoantigen immuno-oncology therapies developer.

37
$12M · Series B Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management 1 to 10 Health Tech Cambridge, UK •••••••••••@neophore.com
Devo

Devo is a cybersecurity company that provides cloud-native logging and security analytics for organizations.

37
$100M Bessemer Venture Partners, Kibo Ventures, Insight Venture Partners 251 to 500 Cybersecurity, Data and Analytics, Privacy and Security, Business Intelligence, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@devo.com
Broken String Biosciences

Genomics company building safer cell and gene therapies.

31
$15M · Series A Tencent, Illumina Ventures 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@brokenstringbio.com
Risilience

Climate analytics and risk assessement.

31
$26M · Series B IQ Capital Partners 11 to 50 Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@risilience.com
Supplant

Supplant is a biotechnology platform that makes sugar substitutes.

31
$24M Khosla Ventures, Felicis Ventures, Y Combinator 11 to 50 Health Tech, Foodtech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@supplant.com
evonetix

DNA synthesis technology researcher.

31
$24M · Series B Foresite Capital 11 to 50 Biotech Cambridge, UK •••••••••••@evonetix.com
Mosaic Therapeutics

Anti-cancer drug developer.

31
$28M · Series A Syncona Partners LLP, Cambridge Innovation Capital 101 to 250 Biotech Cambridge, UK •••••••••••@mosaic-tx.com
TidalSense

AI-driven tech for respiratory conditions.

31
$9M · Series A Business Growth Fund, Downing Ventures 11 to 50 Health Tech, AI Cambridge, UK •••••••••••@tidalsense.com
Nuclera

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

31
$42M · Series B Future Planet Capital, Amadeus Capital, Verve Ventures 11 to 50 Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@nuclera.com
bit.bio

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

31
$41M · Series A Metaplanet Holdings, BlueYard Capital 101 to 250 Health Tech, Biotech, Deep Tech, Business Intelligence B2B Cambridge, UK •••••••••••@bit.bio
Mogrify

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

31
$10M · Series A Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors 101 to 250 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@mogrify.co.uk
Cyted

Cancer diagnostics.

31
$16M · Series A Business Growth Fund 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cyted.ai
Endomag

Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.

31
$20M · Series D Molten Ventures 51 to 100 Health Tech, Hardware B2B Cambridge, UK •••••••••••@endomag.com
Unitary

AI-driven visual content moderation platform.

31
$15M · Series A January Ventures, Creandum, Plural 11 to 50 AI, Sales and Marketing B2B, SaaS Cambridge, UK •••••••••••@unitary.ai
Nu Quantum

Nu Quantum is a telecommunications company that develops end-to-end quantum cryptography systems.

31
$7M · Seed Expeditions Fund, IQ Capital Partners, Amadeus Capital 1 to 10 Hardware, Cybersecurity, Manufacturing, Communications B2B Cambridge, UK •••••••••••@nu-quantum.com
Metrion Biosciences

Metrion Biosciences is a Contract Research Organization.

31
$4M · Series A Gresham House Ventures, NPIF Maven Equity Finance 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@metrionbiosciences.com
PlaqueTecJUST ADDED HIRING

Bioinformatics discovery platform.

29
$8M · Series A Future Fund 1 to 10 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@plaquetec.com
Foundries.io

Foundries.io delivers secure, over-the-air updatable software platforms for embedded product development.

26
$8M · Series A BACKED VC, Crane Venture Partners, IQ Capital Partners 11 to 50 B2B, SaaS Cambridge, UK •••••••••••@foundries.io
Speechmatics

Speechmatics is a software company that provides automous speech and voice recognition technology for live and pre-recorded media.

26
$8M · Series A AlbionVC, IQ Capital Partners 101 to 250 Music and Audio, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@speechmatics.com
Eagle Genomics

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

26
$3M · Seed ETF Partners, Granpool Innovative Investments 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@eaglegenomics.com
Axol Bioscience

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
Cambridge GaN Devices

Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics.

26
$19M IQ Capital Partners, Cambridge Innovation Capital, Business Growth Fund 11 to 50 Manufacturing B2B Cambridge, UK •••••••••••@camgandevices.com
Signaloid

Cloud-based computing platform.

26
$3M · Seed IQ Capital Partners, Creator Fund 11 to 50 Hardware, Manufacturing B2B Cambridge, UK •••••••••••@signaloid.ai
Agile Analog

Supplier of configurable process node agnostic analog IP building blocks.

26
$5M · Seed Omers Ventures, Firstminute Capital, MMC Ventures 11 to 50 Deep Tech, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@agileanalog.com
PillSorted

PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
Cake

Cake is the world's largest platform for helping people navigate end-of-life.

26
$14M Creandum, Headline 1 to 10 Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing B2C Cambridge, UK •••••••••••@joincake.com
Nyobolt

Nyobolt is a developer of high-powered battery technology used to serve automotive applications.

26
$10M · Series A IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Energy & Nuclear, Manufacturing B2B Cambridge, UK •••••••••••@nyobolt.com
PetMedix

PetMedix is a pet therapeutics startup.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

26
$6M · Series A Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments 51 to 100 Health Tech, Biotech Cambridge, UK •••••••••••@missiontherapeutics.com
Epitopea

Epitopea is a transatlantic cancer immunotherapeutics company.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
Qkine

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

26
$5M · Series B Parkwalk Advisors, Downing Ventures 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@qkine.com
Riverlane

OS for quantum computers.

26
$18M · Series B Molten Ventures, Amadeus Capital, Cambridge Innovation Capital 11 to 50 B2B Cambridge, UK •••••••••••@riverlane.com
GeoSpock

GeoSpock builds GeoSpock DB, the unique space-time analytics database that delivers rapid insights at a fraction of the cost.

26
$5M Parkwalk Advisors 11 to 50 Climate Tech & Green Tech, Fintech, Mobile, Data and Analytics, Business Intelligence, Internet of Things, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@geospock.com
Mestag Therapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

26
$11M · Seed GV, Forbion Capital Partners 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@mestagtx.com
Forefront RF

Semiconductor developer.

26
$8M · Series A Business Growth Fund 11 to 50 Hardware, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@forefrontrf.com
Cydar Medical

Precision software for surgeries.

26
$11M · Series A Pembroke VCT 11 to 50 Health Tech B2B, SaaS Cambridge, UK •••••••••••@cydarmedical.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
Flusso

Flusso is in stealth mode, while developing the world's smallest flow sensor.

26
$5M · Series A Parkwalk Advisors, Martlet Capital 11 to 50 Navigation and Mapping, Manufacturing B2B Cambridge, UK •••••••••••@flussoltd.com
Pivotal

Biodiversity measurement platform.

26
$5M · Seed Octopus Ventures 11 to 50 Climate Tech & Green Tech Cambridge, UK •••••••••••@pivotal.earth
Owlstone Medical

Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.

23
$57M · Series D 101 to 250 Health Tech Cambridge, UK •••••••••••@owlstonemedical.com
Cambridge Epigenetix

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

23
$88M · Series D 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cambridge-epigenetix.com
Artios Pharma

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

23
$152M · Series C 101 to 250 Health Tech, Deep Tech Cambridge, UK •••••••••••@artiospharma.com
Gearset

Setting the standard for Salesforce DevOps

23
$55M 101 to 250 Sales and Marketing, Developer Tools B2B, SaaS Cambridge, UK •••••••••••@gearset.com
techspert

Techspert is an AI-driven technology for identifying and sourcing specialist expertise, globally.

21
$4M · Series A Nauta Capital, Business Growth Fund 51 to 100 AI, Business Intelligence B2B, SaaS, Marketplace Cambridge, UK •••••••••••@techspert.com
Sphere Fluidics

Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.

21
$4M Sofinnova Partners 11 to 50 Health Tech, Deep Tech B2B Cambridge, UK •••••••••••@spherefluidics.com
Semarion

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

21
$2M · Seed Parkwalk Advisors, Martlet Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@semarion.com
Fieldwork Robotics

Manufacturer of autonomous harvesting robots.

21
$1M · Seed Elbow Beach Capital 1 to 10 Robotics, Manufacturing B2B Cambridge, UK •••••••••••@fieldworkrobotics.com
World Makers

Social multi-player gaming studio.

21
$4M · Series A Makers Fund 1 to 10 Foodtech, Gaming, CPG & Consumer Goods, Consumer Social, Community & Lifestyle B2C Cambridge, UK •••••••••••@worldmakers.com
HexagonFab

HexagonFab is the biological sensor for rapid and cost-effective detection of biological substances.

21
$2M · Seed Parkwalk Advisors 1 to 10 Hardware, Biotech, Manufacturing, Business Intelligence B2B Cambridge, UK •••••••••••@hexagonfab.com
KisanHub

KisanHub Agri-Food Supply Chain Software helps Producer Groups to transform their supply chains

21
$4M · Series A Notion Capital, IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Agritech B2B, SaaS Cambridge, UK •••••••••••@kisanhub.com
Luminance HIRING

Generative AI platform for law firms.

21
$3M · Seed Talis Capital, National Grid Partners (NGP), March Capital 101 to 250 AI, Legal Tech B2B, SaaS Cambridge, UK •••••••••••@luminance.com
Xampla

Plant-based biodegradable material producer.

21
$2M · Seed Amadeus Capital, Horizons Ventures, Parkwalk Advisors 1 to 10 Biotech B2B Cambridge, UK •••••••••••@xampla.com
Storm Therapeutics

Novel cancer therapies.

20
$30M · Series B 11 to 50 Health Tech, Deep Tech B2C Cambridge, UK •••••••••••@stormtherapeutics.com
PhoreMost

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

20
$45M · Series B 1 to 10 Health Tech, Deep Tech Cambridge, UK •••••••••••@phoremost.com
Fetch.ai

Decentralized network.

20
$40M · Series B 11 to 50 Crypto & web3 B2B, SaaS Cambridge, UK •••••••••••@fetch.ai
Cambridge Quantum Computing

CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms.

20
$45M 101 to 250 Hardware, AI, Manufacturing, Enterprise Software, Quantum Computing B2B Cambridge, UK •••••••••••@cambridgequantum.com
OTHER CITIES
OTHER CITIES IN UK